A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer

被引:5
|
作者
Eriksson, Mikael [1 ,2 ]
Czene, Kamila [1 ]
Vachon, Celine [3 ]
Conant, Emily F. [4 ]
Hall, Per [1 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17165 Stockholm, Sweden
[2] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England
[3] Mayo Clin, Coll Med, Dept Quantitat Hlth Sci, Div Epidemiol, Rochester, MN 55905 USA
[4] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
[5] Sodersjukhuset Univ Hosp, Dept Oncol, S-11883 Stockholm, Sweden
关键词
breast cancer; risk model; long-term risk; primary prevention; individualized screening; artificial intelligence; image-derived risk model; FOLLOW-UP; TAMOXIFEN; WOMEN;
D O I
10.3390/cancers15123246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary We investigated the benefits of adding lifestyle and familial risk factors to a mammographic image-derived short-term AI risk model in a 10-year follow-up study for its potential use in personalized screening and prevention of breast cancer (BC). In a case-cohort study, 8110 women were selected from women aged 40-74 participating in a Swedish mammography screening cohort. The women had no BC diagnosis at enrollment. In all, 1661 incident BCs were developed in the case-cohort. The lifestyle/familial-expanded AI risk model showed a significantly higher discriminatory performance in the long term and short term than the imaging-only risk model and the clinical Tyrer-Cuzick v8 model. The expanded model also showed the highest risk classification performance using positive predictive value (PPV). The results suggest that a lifestyle/familial-expanded image-derived AI risk model could most efficiently refine the identification of women who may benefit from personalized screening and/or risk-reducing intervention. Background: Image-derived artificial intelligence (AI) risk models have shown promise in identifying high-risk women in the short term. The long-term performance of image-derived risk models expanded with clinical factors has not been investigated. Methods: We performed a case-cohort study of 8110 women aged 40-74 randomly selected from a Swedish mammography screening cohort initiated in 2010 together with 1661 incident BCs diagnosed before January 2022. The imaging-only AI risk model extracted mammographic features and age at screening. Additional lifestyle/familial risk factors were incorporated into the lifestyle/familial-expanded AI model. Absolute risks were calculated using the two models and the clinical Tyrer-Cuzick v8 model. Age-adjusted model performances were compared across the 10-year follow-up. Results: The AUCs of the lifestyle/familial-expanded AI risk model ranged from 0.75 (95%CI: 0.70-0.80) to 0.68 (95%CI: 0.66-0.69) 1-10 years after study entry. Corresponding AUCs were 0.72 (95%CI: 0.66-0.78) to 0.65 (95%CI: 0.63-0.66) for the imaging-only model and 0.62 (95%CI: 0.55-0.68) to 0.60 (95%CI: 0.58-0.61) for Tyrer-Cuzick v8. The increased performances were observed in multiple risk subgroups and cancer subtypes. Among the 5% of women at highest risk, the PPV was 5.8% using the lifestyle/familial-expanded model compared with 5.3% using the imaging-only model, p < 0.01, and 4.6% for Tyrer-Cuzick, p < 0.01. Conclusions: The lifestyle/familial-expanded AI risk model showed higher performance for both long-term and short-term risk assessment compared with imaging-only and Tyrer-Cuzick models.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Notes on breast cancer prevention and screening
    Koest, Hans-Peter
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2015, 8 (03) : 198 - 200
  • [42] In the Clinic Breast Cancer Screening and Prevention
    Farkas, Amy H.
    Nattinger, Ann B.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : ITC161 - ITC176
  • [43] An Update on Breast Cancer Screening and Prevention
    de la Cruz, Maria Syl D.
    Sarfaty, Mona
    Wender, Richard C.
    PRIMARY CARE, 2014, 41 (02): : 283 - +
  • [44] Notes on breast cancer prevention and screening
    Hans-Peter Köst
    memo - Magazine of European Medical Oncology, 2015, 8 (3) : 198 - 200
  • [45] Breast Cancer Epidemiology, Prevention, and Screening
    Winters, Stella
    Martin, Charmaine
    Murphy, Daniel
    Shokar, Navkiran K.
    APPROACHES TO UNDERSTANDING BREAST CANCER, 2017, 151 : 1 - 32
  • [46] Risk Prediction of Gastric Cancer in Asian Populations: its Potential Application to Personalized Prevention and Screening
    Tsugane, Shoichiro
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 : 47 - 48
  • [47] The Role of Genome Sequencing in Personalized Breast Cancer Prevention
    Sieh, Weiva
    Rothstein, Joseph H.
    McGuire, Valerie
    Whittemore, Alice S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11) : 2322 - 2327
  • [48] Screening Whole Breast Ultrasound: An Opportunity to Move to Personalized, Effective Breast Cancer Screening
    Brem, Rachel F.
    BREAST JOURNAL, 2012, 18 (06): : 515 - 516
  • [49] Personalized approach increases breast cancer screening rates
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (08): : 1243 - 1243
  • [50] Mammographic Density for Personalized Breast Cancer Risk
    Kataoka, Masako
    RADIOLOGY, 2023, 306 (02)